Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQHHA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,661
Award facts
- Contract value 100% obligated
- $2,661.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,661.00 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on July 29, 2025, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp functions as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The parent IDC encompasses a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains. This specific delivery order for TDAP vaccines reflects the company's ongoing role in supplying essential immunization products to support federal health programs. The DLA is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue as a key supplier within the modernized procurement framework.
Quick answers
Who was awarded contract SPE2DB25FQHHA?
SPE2DB25FQHHA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FQHHA worth?
The government has obligated $2,661 on SPE2DB25FQHHA.
Is contract SPE2DB25FQHHA an order under another contract?
Yes. SPE2DB25FQHHA is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHHA competed?
The extent of competition for SPE2DB25FQHHA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award